肺癌分子靶点治疗的研究进展(8)
24Claudio PP, Howard CM, Pacilio C, et al. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res, 2000 ,60(2):372-382
25Jiu, X, Nguyen, D, Zhang, WW, et al. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res,1995 ,55(15):3250-3253
26Kawabe S, Roth JA, Wilson DR, et al. Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner. Oncogene, 2000,19(47):5359-5366
, 百拇医药
27Sporn, MB, Todaro, GJ. Autocrine growth factors and cancer. Nature,1985,313;747-751
28Bos, M, Mendelsohn, J, Bowden, D, et al. Phase I studies of anti-epidermal growth factor receptor (EGFR) chimeric monoclonal antibody C225 in patients with EGFR overexpressing tumors . Proc Am Soc Clin Oncol ,1996,15:443
29Shaw, JP, Akiyoshi, DE, Arrijo, DA, et al . Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. J Biol Chem ,1991,51(15):2118-2124
, 百拇医药
30Bos, M, Mendelsohn, J, Kim, YM, et al . PD 153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res ,1997,3(11):2099-2106
31Vollman, AM, Banker, DE, Mendelsohn, J, et al . Toxicity of ligand and antibody-directed ricin A chain conjugates recognizing the epidermal growth factor receptor. J Cell Physiol ,1987,131(3):418-425
, http://www.100md.com
32Fontanini, G, DeLaurentis, M, Vignati, S, et al . Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res,1998, 4(1):241-249
33吴一龙.肺癌临床研究的回顾与展望.中国肿瘤,2002，11(1)：9-10
34Raben D, Helfrich BA, Chan D, et al. ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin Onco,l 2002 ,29(1 Suppl 4):37-46
, 百拇医药
35Bunn, PA, Jr, Chan, D, Stewart, J, et al. Effects of neuropeptides analogs on calcium flux and proliferation in lung cancer cell lines. Cancer Res,1994,54(13):3602-3610
36Heasley, LE, Zamarripa, J, Storey, B, et al . Discordant signal transduction and growth inhibition of small cell lung carcinomas induced by expression of GTPase deficient Ga16. J Biol Chem,1996,271(1):349-356, 百拇医药(乔贵宾 吴一龙)
25Jiu, X, Nguyen, D, Zhang, WW, et al. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res,1995 ,55(15):3250-3253
26Kawabe S, Roth JA, Wilson DR, et al. Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner. Oncogene, 2000,19(47):5359-5366
, 百拇医药
27Sporn, MB, Todaro, GJ. Autocrine growth factors and cancer. Nature,1985,313;747-751
28Bos, M, Mendelsohn, J, Bowden, D, et al. Phase I studies of anti-epidermal growth factor receptor (EGFR) chimeric monoclonal antibody C225 in patients with EGFR overexpressing tumors . Proc Am Soc Clin Oncol ,1996,15:443
29Shaw, JP, Akiyoshi, DE, Arrijo, DA, et al . Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. J Biol Chem ,1991,51(15):2118-2124
, 百拇医药
30Bos, M, Mendelsohn, J, Kim, YM, et al . PD 153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res ,1997,3(11):2099-2106
31Vollman, AM, Banker, DE, Mendelsohn, J, et al . Toxicity of ligand and antibody-directed ricin A chain conjugates recognizing the epidermal growth factor receptor. J Cell Physiol ,1987,131(3):418-425
, http://www.100md.com
32Fontanini, G, DeLaurentis, M, Vignati, S, et al . Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res,1998, 4(1):241-249
33吴一龙.肺癌临床研究的回顾与展望.中国肿瘤,2002，11(1)：9-10
34Raben D, Helfrich BA, Chan D, et al. ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin Onco,l 2002 ,29(1 Suppl 4):37-46
, 百拇医药
35Bunn, PA, Jr, Chan, D, Stewart, J, et al. Effects of neuropeptides analogs on calcium flux and proliferation in lung cancer cell lines. Cancer Res,1994,54(13):3602-3610
36Heasley, LE, Zamarripa, J, Storey, B, et al . Discordant signal transduction and growth inhibition of small cell lung carcinomas induced by expression of GTPase deficient Ga16. J Biol Chem,1996,271(1):349-356, 百拇医药(乔贵宾 吴一龙)